Rob Agnew

Background

About Rob Agnew

Currently, Key Account Manager-South (Bleeding Management)Responsible for driving strategic growth strengthening clinical partnerships, and bleeding management solutions across key health systems in the southern U.S. including Florida, Georgia, South Carolina, North Carolina, Virginia, Alabama, Tennessee, Mississippi, Louisiana and Texas. Collaborate with the hospital team and National Accounts to lead strategic initiatives with IDN's to ensure Bleeding Management portfolio are available in hospitals and IDN's.Previously, Southeast Regional Sales Director at Verrica Pharmaceuticals, driving dermatology innovation and team success. Directed the launch of a pioneering treatment for Molluscum Contagiosum, developed comprehensive training programs, and enhanced sales outcomes through Buy and Bill reimbursement strategies, contributing to top-tier President’s Club performance recognition. Startup Company went through a re-organization, which led me to my current employer, Grifols!Previously, as Senior Regional Sales Manager at Viatris, led the Southeast team to multiple President’s Club awards by implementing specialty pharmacy models and addressing market challenges. Collaborated on product launches with Shield Therapeutics and successfully built and trained a high-performing team. Committed to leveraging strategic insights, fostering team excellence, and delivering impactful results in complex pharmaceutical markets. Left my 16-year career to pursue a startup opportunity at Verrica.From 2017-2019 I led the Southeast team at Mylan/Viatris in their Dermatology business. We had a robust product profile selling upwards of 5 to 6 products during my tenure. The team finished near the bottom, my first year and through a new strategy and adding specialty pharmacies in our region the southeast team finished in first place in 2018. I won President’s Club along with my team placing all five of the Presidents Club rep positions. In 2019 we were trending at number one yet again, unfortunately midway through the year the Dermatology business was dissolved.